Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Janssens (Leuven, Belgium). Pharmacological treatments. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC

Member's Comments

No comment yet.

Related content which might interest you: Pharmacological treatment Source: International Congress 2017 – Latest GOLD update Year: 2017 Pharmacological management Source: Eur Respir Monogr 2016; 71: 196-217 Year: 2016 Pharmacological approach Source: Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease Year: 2006 Pharmacological and Non-pharmacological therapies that modulare lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021 Treatment of COPD: from pharmacological to instrumental therapies Source: Eur Respir Rev 2009; 19: 7-23 Year: 2010 Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 Pharmacological treatment & current controversies in asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Pharmacological prevention of VAP Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia Year: 2003 Pharmacological properties of a novel PI3Kd inhibitor, DS-1515 Source: International Congress 2018 – Basic pharmacology Year: 2018 Pharmacological induction of A20: Anti-inflammatory effects in paediatric asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019